Andrew O Wahl MD

Associate Professor and Residency Program Director, Radiation Oncology, University of Nebraska Medical Center College of Medicine

Join to View Full Profile

987521 Nebraska Medical CtrOmaha, NE 68198
Phone+1 402-552-3844
Fax+1 402-552-3013

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Radiation Oncology, 2004 - 2008
Creighton University School of Medicine (Omaha)Internship, Internal Medicine, 2003 - 2004
University of Nebraska College of MedicineClass of 2003

Certifications & Licensure

IA State Medical License 2008 - 2027
NE State Medical License 2008 - 2026
IL State Medical License 2007 - 2008
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
COMPLETED
PHASE2, PHASE3
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
COMPLETED
PHASE3
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
COMPLETED
PHASE3
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2010 Mar 01
Completed
Phase 2
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2011 Mar 01
Completed
Phase 2
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery Start of enrollment: 2011 Oct 01
Completed
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
COMPLETED
PHASE3
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE Start of enrollment: 2014 Jun 30
COMPLETED
PHASE2
Join now to see all

Publications & Presentations

PubMed

1 citations
Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas.
Tracy Sherertz, Anuja Jhingran, Matthew Biagioli, David Gaffney, Mohamed Elshaikh
International Journal of Gynecological Cancer. 2022-12-05
29 citations
Percentage of Hormone Receptor Positivity in Breast Cancer Provides Prognostic Value: A Single-Institute Study.
Richard Sleightholm, Beth K. Neilsen, Safwan Elkhatib, Laura E. Flores, Saihari S. Dukkipati
Journal of Clinical Medicine Research. 2021-01-11
3 citations
Diffuse lesions secondary to sarcoidosis mimicking widespread metastatic breast cancer: A case report.
Heidi Vieira, Beth K. Neilsen, Richard Sleightholm, Jordan Hankins, Alison G. Freifeld
Clinical Case Reports. 2021-01-01

Andrew O Wahl MD

Dr. Wahl is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.